Question

A 58-year-old man with type 2 diabetes has HbA1c 8.9% (74 mmol/mol) despite maximum tolerated metformin. BMI is 33 kg/m², eGFR 70 mL/min/1.73 m² and he has established cardiovascular disease. According to contemporary Australian guidance, which additional agent is preferred?

Accepted Answer

SGLT2 inhibitor

Answer

Sulfonylurea

Answer

Basal insulin

Answer

Thiazolidinedione

Answer

DPP-4 inhibitor

Practice question

A 58-year-old man with type 2 diabetes has HbA1c 8.9% (74 mmol/mol) despite maximum tolerated metformin. BMI is 33 kg/m², eGFR 70 mL/min/1.73 m² and he has established cardiovascular disease. According to contemporary Australian guidance, which additional agent is preferred?